nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—Bone marrow depression—Teniposide—lymphatic system cancer	0.0277	0.0277	CcSEcCtD
Carbimazole—Bone marrow depression—Fludarabine—lymphatic system cancer	0.0243	0.0243	CcSEcCtD
Carbimazole—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.0204	0.0204	CcSEcCtD
Carbimazole—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Carbimazole—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.015	0.015	CcSEcCtD
Carbimazole—Bone marrow depression—Vincristine—lymphatic system cancer	0.0149	0.0149	CcSEcCtD
Carbimazole—Bone marrow depression—Mitoxantrone—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Carbimazole—Jaundice—Mechlorethamine—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Carbimazole—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Carbimazole—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Carbimazole—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Carbimazole—Liver function test abnormal—Teniposide—lymphatic system cancer	0.0125	0.0125	CcSEcCtD
Carbimazole—Alopecia—Mechlorethamine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Carbimazole—Contusion—Mitoxantrone—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Carbimazole—Pancytopenia—Teniposide—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Carbimazole—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Carbimazole—Neutropenia—Teniposide—lymphatic system cancer	0.011	0.011	CcSEcCtD
Carbimazole—Stomatitis—Teniposide—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Carbimazole—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00992	0.00992	CcSEcCtD
Carbimazole—Pancytopenia—Fludarabine—lymphatic system cancer	0.00978	0.00978	CcSEcCtD
Carbimazole—Neutropenia—Fludarabine—lymphatic system cancer	0.00963	0.00963	CcSEcCtD
Carbimazole—Haemoglobin—Teniposide—lymphatic system cancer	0.00943	0.00943	CcSEcCtD
Carbimazole—Haemorrhage—Teniposide—lymphatic system cancer	0.00938	0.00938	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00937	0.00937	CcSEcCtD
Carbimazole—Mouth ulceration—Vincristine—lymphatic system cancer	0.00907	0.00907	CcSEcCtD
Carbimazole—Infection—Mechlorethamine—lymphatic system cancer	0.00898	0.00898	CcSEcCtD
Carbimazole—Stomatitis—Fludarabine—lymphatic system cancer	0.00895	0.00895	CcSEcCtD
Carbimazole—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00885	0.00885	CcSEcCtD
Carbimazole—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00878	0.00878	CcSEcCtD
Carbimazole—Alopecia—Teniposide—lymphatic system cancer	0.00829	0.00829	CcSEcCtD
Carbimazole—Haemoglobin—Fludarabine—lymphatic system cancer	0.00829	0.00829	CcSEcCtD
Carbimazole—Haemorrhage—Fludarabine—lymphatic system cancer	0.00825	0.00825	CcSEcCtD
Carbimazole—Leukopenia—Teniposide—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Carbimazole—Alopecia—Fludarabine—lymphatic system cancer	0.00729	0.00729	CcSEcCtD
Carbimazole—Bone marrow depression—Methotrexate—lymphatic system cancer	0.00721	0.00721	CcSEcCtD
Carbimazole—Pancytopenia—Bleomycin—lymphatic system cancer	0.00717	0.00717	CcSEcCtD
Carbimazole—Liver disorder—Methotrexate—lymphatic system cancer	0.00714	0.00714	CcSEcCtD
Carbimazole—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00704	0.00704	CcSEcCtD
Carbimazole—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00666	0.00666	CcSEcCtD
Carbimazole—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00666	0.00666	CcSEcCtD
Carbimazole—Infection—Teniposide—lymphatic system cancer	0.00662	0.00662	CcSEcCtD
Carbimazole—Stomatitis—Bleomycin—lymphatic system cancer	0.00656	0.00656	CcSEcCtD
Carbimazole—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00653	0.00653	CcSEcCtD
Carbimazole—Malaise—Fludarabine—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Carbimazole—Leukopenia—Fludarabine—lymphatic system cancer	0.00643	0.00643	CcSEcCtD
Carbimazole—Pruritus—Mechlorethamine—lymphatic system cancer	0.0064	0.0064	CcSEcCtD
Carbimazole—Pancytopenia—Carmustine—lymphatic system cancer	0.00626	0.00626	CcSEcCtD
Carbimazole—Neutropenia—Carmustine—lymphatic system cancer	0.00617	0.00617	CcSEcCtD
Carbimazole—Arthralgia—Fludarabine—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Carbimazole—Myalgia—Fludarabine—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Carbimazole—Haemoglobin—Bleomycin—lymphatic system cancer	0.00608	0.00608	CcSEcCtD
Carbimazole—Haemorrhage—Bleomycin—lymphatic system cancer	0.00605	0.00605	CcSEcCtD
Carbimazole—Discomfort—Fludarabine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Carbimazole—Pancytopenia—Vincristine—lymphatic system cancer	0.00598	0.00598	CcSEcCtD
Carbimazole—Neutropenia—Vincristine—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Carbimazole—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00582	0.00582	CcSEcCtD
Carbimazole—Infection—Fludarabine—lymphatic system cancer	0.00582	0.00582	CcSEcCtD
Carbimazole—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00575	0.00575	CcSEcCtD
Carbimazole—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00574	0.00574	CcSEcCtD
Carbimazole—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Carbimazole—Stomatitis—Carmustine—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Carbimazole—Rash—Mechlorethamine—lymphatic system cancer	0.0057	0.0057	CcSEcCtD
Carbimazole—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0057	0.0057	CcSEcCtD
Carbimazole—Feeling abnormal—Teniposide—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Carbimazole—Stomatitis—Vincristine—lymphatic system cancer	0.00547	0.00547	CcSEcCtD
Carbimazole—Nausea—Mechlorethamine—lymphatic system cancer	0.00537	0.00537	CcSEcCtD
Carbimazole—Alopecia—Bleomycin—lymphatic system cancer	0.00534	0.00534	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00534	0.00534	CcSEcCtD
Carbimazole—Jaundice—Mitoxantrone—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Carbimazole—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Carbimazole—Haemoglobin—Carmustine—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Carbimazole—Urticaria—Teniposide—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Carbimazole—Haemorrhage—Carmustine—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Carbimazole—Body temperature increased—Teniposide—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Carbimazole—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Carbimazole—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00493	0.00493	CcSEcCtD
Carbimazole—Hypersensitivity—Teniposide—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Carbimazole—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Carbimazole—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Carbimazole—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00488	0.00488	CcSEcCtD
Carbimazole—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Carbimazole—Malaise—Bleomycin—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Carbimazole—Pruritus—Teniposide—lymphatic system cancer	0.00472	0.00472	CcSEcCtD
Carbimazole—Leukopenia—Bleomycin—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Carbimazole—Alopecia—Carmustine—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Carbimazole—Body temperature increased—Fludarabine—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Carbimazole—Angiopathy—Vincristine—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Carbimazole—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Carbimazole—Myalgia—Bleomycin—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Carbimazole—Alopecia—Vincristine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Carbimazole—Discomfort—Bleomycin—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Carbimazole—Mouth ulceration—Methotrexate—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Carbimazole—Alopecia—Mitoxantrone—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Carbimazole—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Carbimazole—Infection—Bleomycin—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Carbimazole—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00421	0.00421	CcSEcCtD
Carbimazole—Rash—Teniposide—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Carbimazole—Dermatitis—Teniposide—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Carbimazole—Headache—Teniposide—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Carbimazole—Pruritus—Fludarabine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Carbimazole—Leukopenia—Carmustine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Carbimazole—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Carbimazole—Nausea—Teniposide—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Carbimazole—Leukopenia—Vincristine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Carbimazole—Myalgia—Carmustine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Carbimazole—Malaise—Mitoxantrone—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Carbimazole—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Carbimazole—Myalgia—Vincristine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Carbimazole—Infection—Carmustine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Carbimazole—Rash—Fludarabine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Carbimazole—Dermatitis—Fludarabine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Carbimazole—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Carbimazole—Headache—Fludarabine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Carbimazole—Myalgia—Mitoxantrone—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Carbimazole—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Carbimazole—Discomfort—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Carbimazole—Infection—Vincristine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Carbimazole—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Carbimazole—Nervous system disorder—Vincristine—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Carbimazole—Thrombocytopenia—Vincristine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Carbimazole—Nausea—Fludarabine—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Carbimazole—Infection—Mitoxantrone—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Carbimazole—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Carbimazole—Urticaria—Bleomycin—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Carbimazole—Body temperature increased—Bleomycin—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Carbimazole—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Carbimazole—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Carbimazole—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Carbimazole—Feeling abnormal—Carmustine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Carbimazole—Pruritus—Bleomycin—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Carbimazole—Eosinophilia—Methotrexate—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Carbimazole—Body temperature increased—Carmustine—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Carbimazole—Pancytopenia—Methotrexate—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Carbimazole—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Carbimazole—Neutropenia—Methotrexate—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Carbimazole—Body temperature increased—Vincristine—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Carbimazole—Urticaria—Mitoxantrone—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Carbimazole—Hypersensitivity—Carmustine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Carbimazole—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Carbimazole—Rash—Bleomycin—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Carbimazole—Dermatitis—Bleomycin—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Carbimazole—Stomatitis—Methotrexate—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Carbimazole—Hypersensitivity—Vincristine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Carbimazole—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Carbimazole—Nausea—Bleomycin—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Carbimazole—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Carbimazole—Haemoglobin—Methotrexate—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Carbimazole—Haemorrhage—Methotrexate—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Carbimazole—Hepatitis—Methotrexate—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Carbimazole—Rash—Carmustine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Carbimazole—Dermatitis—Carmustine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Carbimazole—Headache—Carmustine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Carbimazole—Rash—Vincristine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Carbimazole—Dermatitis—Vincristine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Carbimazole—Headache—Vincristine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Carbimazole—Nausea—Carmustine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Carbimazole—Angiopathy—Methotrexate—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Carbimazole—Rash—Mitoxantrone—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Carbimazole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Carbimazole—Headache—Mitoxantrone—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Carbimazole—Alopecia—Methotrexate—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Carbimazole—Nausea—Vincristine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Carbimazole—Nausea—Mitoxantrone—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Carbimazole—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Carbimazole—Malaise—Methotrexate—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Carbimazole—Leukopenia—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Carbimazole—Myalgia—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Carbimazole—Arthralgia—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Carbimazole—Discomfort—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Carbimazole—Infection—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Carbimazole—Nervous system disorder—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Carbimazole—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Carbimazole—Skin disorder—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Carbimazole—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Carbimazole—Urticaria—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Carbimazole—Body temperature increased—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Carbimazole—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Carbimazole—Pruritus—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Carbimazole—Rash—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Carbimazole—Dermatitis—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Carbimazole—Headache—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Carbimazole—Nausea—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
